the LBT most recent news is good but it would appear the momentum is falling away quickly.
it would be nice to see urine and VRE CE marked this quarter as was stated in the guidance in Q4 2021. VRE for FDA. approval in Q2 2022 would be nice too.
i believe lbt has turned a corner with thermo selling some instruments but we need some momentum.
Ann: Purchase Order for Multiple APAS Instruments, page-35
-
- There are more pages in this discussion • 27 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add LBT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.6¢ |
Change
0.001(3.23%) |
Mkt cap ! $27.98M | |||
| Open | High | Low | Value | Volume |
| 1.6¢ | 1.6¢ | 1.6¢ | $31.62K | 1.976M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 1847724 | 1.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.6¢ | 1063750 | 2 |
View Market Depth
| Last trade - 16.10pm 18/10/2024 (20 minute delay) ? |
| LBT (ASX) Chart |